Skip to content

    BIOGEN INC.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $2.46B
    $2.47B
    $2.45B
    $2.43B
    $2.65B
    +7.3%
    $2.53B
    +2.8%
    $2.28B
    -7.1%
    $2.48B
    +1.9%
    Stable
    Operating Profit
    Net Profit
    $583.60M
    $388.50M
    $266.70M
    $240.50M
    $634.80M
    +8.8%
    $466.50M
    +20.1%
    -$48.90M
    -118.3%
    $319.50M
    +32.8%
    Weakening
    EPS
    $4.01
    $2.67
    $1.65
    $4.33
    +8.0%
    $3.18
    +19.1%
    $2.17
    +31.5%
    Strengthening
    Other Income
    Interest
    $61.30M
    $59.80M
    $60.00M
    $60.00M
    $72.60M
    +18.4%
    $67.40M
    +12.7%
    $67.50M
    +12.5%
    $67.60M
    +12.7%
    Strengthening
    Depreciation
    Profit before Tax
    $698.70M
    $451.00M
    $291.50M
    $311.20M
    $744.00M
    +6.5%
    $557.30M
    +23.6%
    -$56.00M
    -119.2%
    $377.70M
    +21.4%
    Weakening
    MarginsOPM
    Tax
    16.5%
    13.9%
    8.5%
    22.7%
    14.7%
    -10.9%
    16.3%
    +17.5%
    12.7%
    +49.0%
    15.4%
    -32.2%
    Strengthening
    ReturnsROIC
    2.8%
    1.9%
    1.3%
    1.2%
    3.0%
    +8.8%
    2.2%
    +20.1%
    -0.2%
    -118.3%
    1.5%
    +32.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$1.22B$2.91B$1.33B$2.26B$3.42B$1.05B$2.38B$3.01B$3.38B
    Short-Term Investments
    Total Current Assets$7.64B$8.38B$6.89B$7.86B$9.79B$6.86B$7.46B$8.97B$9.19B
    Net PP&E$3.60B$3.67B$3.84B$3.79B$3.70B$3.73B$3.54B$3.32B$3.27B
    Goodwill$5.71B$5.76B$5.76B$5.76B$5.75B$6.22B$6.48B$6.49B$6.49B
    Intangibles$3.12B$3.53B$3.08B$2.22B$1.85B$8.36B$9.69B$9.18B$9.05B
    Total Assets$25.29B$27.23B$24.62B$23.88B$24.55B$26.84B$28.05B$29.44B$29.48B
    LiabilitiesTotal Current Liabilities$3.30B$4.86B$3.74B$4.30B$3.27B$3.43B$5.53B$3.35B$3.00B
    Short-Term Debt$0$1.50B$0$999.10M$0$150.00M$1.75B$0
    Long-Term Debt$5.94B$4.46B$7.43B$6.27B$6.28B$6.79B$4.55B$6.29B$6.29B
    Long-Term Leases$0$412.70M$402.00M$330.40M$333.00M$400.00M$334.50M$290.40M$273.40M
    Total Liabilities$12.26B$13.90B$13.93B$12.92B$11.17B$12.05B$11.33B$11.18B$10.83B
    EquityCommon Stock & APIC$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K
    Retained Earnings$16.26B$16.46B$13.98B$13.91B$16.47B$17.63B$19.26B$20.55B$20.87B
    Total Equity$13.04B$13.34B$10.70B$10.90B$13.40B$14.80B$16.72B$18.26B$18.65B
    HighlightsNet Cash / (Debt)-$4.71B-$3.04B-$6.09B-$5.01B-$2.86B-$5.89B-$3.92B-$3.28B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$6.19B$7.08B$4.23B$3.64B$1.38B$1.55B$2.88B$2.20B$2.59B
    Cash from Investing-$2.05B$470.50M-$608.60M-$563.70M$1.58B-$4.10B-$799.20M-$1.37B-$1.53B
    Cash from Financing-$4.47B-$5.86B-$5.27B-$2.09B-$1.75B$149.30M-$683.50M-$301.90M-$322.70M
    SummaryCapital Expenditure-$770.60M-$514.50M-$424.80M-$258.10M-$240.30M-$277.00M-$153.70M-$153.80M-$167.90M
    Free Cash Flow$5.42B$6.56B$3.81B$3.38B$1.14B$1.27B$2.72B$2.05B$2.42B
    FCF Margin40.3%45.7%28.3%30.8%11.2%12.9%28.1%20.7%24.4%